Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial-Reference-Cited by-同舟云学术

Safety, immunogenicity and protection of heterologous boost with an aerosolised Ad5-nCoV after two-dose inactivated COVID-19 vaccines in adults: a multicentre, open-label phase 3 trial

Published:2023-10 Issue:10 Volume:23 Page:1143-1152
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Li Jing-Xin,Hou Li-Hua,Gou Jin-Bo,Yin Zun-Dong,Wu Shi-Po,Wang Fu-Zhen,Zhang Zhe,Peng Zhi-Hang,Zhu Tao,Shen Hong-Bing,Chen Wei,Zhu Feng-Cai,Jia Si-Yue,Tang Rong,Pan Hong-Xing,Zhang Li,Xu Jia-Wei,Tang Ji-Hai,Wang Qing,Xu Qing,Zheng Yan,Huang Tao,Li Tao,Liu Shu-Jun,Wang Cang-Ning

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference20 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019;Zhu;N Engl J Med,2020

2. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet,2022

3. Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case-control study;Tartof;Lancet Respir Med,2022

4. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant;Andrews;N Engl J Med,2022

5. Effectiveness and durability of the BNT162b2 vaccine against omicron sublineages in South Africa;Collie;N Engl J Med,2022

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19;Frontiers in Immunology;2024-09-12

2. The delivery device of SARS-CoV-2 mucosal vaccine matters;Nature Immunology;2024-09-03

3. A retrospective survey on the effectiveness of vaccines administered to individuals in China with regard to inactivated COVID-19 vaccines, Ad5-nCoV and/or aerosolized Ad5-nCoV;Emerging Microbes & Infections;2024-08-30

4. Intranasal SARS-CoV-2 Omicron variant vaccines elicit humoral and cellular mucosal immunity in female mice;eBioMedicine;2024-07

5. Molecular basis of Ad5-nCoV Vaccine-Induced Immunogenicity;2024-06-21